Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Constellium    CSTM   NL0010489522

My previous session
Most popular
Analysis summaryMarketScreener Strategies

David Meurisse

Contributor / Partner
share with twitter share with LinkedIn share with facebook
share via e-mail

Is the distribution phase coming to an end ?

Strategy published on 03/13/2018 | 16:10
long trade
Stop-loss triggered
Entry price : 12.15$ | Target : 13.7$ | Stop-loss : 11.2$ | Potential : 12.76%
The price of Constellium shares is range-bound. This phase will end sooner or later when volatility comes back.
Investors have an opportunity to buy the stock and target the $ 13.7.
  • The company has solid fundamentals for a short-term investment strategy.

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.54 for the 2018 fiscal year.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 8.59 USD

  • Stock prices approach a strong long-term resistance in weekly data at USD 13.1.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company's earnings releases usually do not meet expectations.
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2018 6 577 M
EBIT 2018 340 M
Net income 2018 90,3 M
Debt 2018 2 152 M
Yield 2018 -
P/E ratio 2018 17,80
P/E ratio 2019 9,29
EV / Sales 2018 0,58x
EV / Sales 2019 0,54x
Capitalization 1 676 M
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
Yield -
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
Constellium Technical Analysis Chart | MarketScreener
Duration : Period : Week
Constellium Technical Analysis Chart | MarketScreener